Search

Search Results

• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  Published: 9 September 2016

  2864

  PDF: 2130
• 

  Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

  S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

  158-165

  19-07-2012

  Published: 19 July 2012

  937

  PDF: 791
• 

  Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

  GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

  388-394

  20-12-2012

  Published: 20 December 2012

  3790

  PDF: 2140
• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  Published: 17 March 2014

  2422

  PDF: 1307
• 

  Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases

  L. Degli Esposti, L. Sinigaglia, M. Rossini, S. Adami, C. Cagnoni, C. Magliaro, C. Veronesi, S. Buda, S. Minisola

  18-26

  16-03-2012

  Published: 16 March 2012

  1442

  PDF: 928
• 

  The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

  M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

  188-194

  31-12-2016

  Published: 31 December 2016

  1588

  PDF: 886
• 

  A case of mandible Paget’s disease of the bone treated with intravenous neridronate

  A. Fassio, L. Idolazzi, M. Rossini, O. Viapiana, D. Gatti

  154-158

  16-12-2016

  Published: 16 December 2016

  1709

  PDF: 977
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  Published: 22 May 2017

  4108

  PDF: 2910
• 

  Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

  A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

  63-74

  27-05-2013

  Published: 27 May 2013

  6940

  PDF: 3667
• 

  Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

  A. Loi, S. Lisci, A. Denotti, A. Cauli

  121-125

  24-07-2013

  Published: 24 July 2013

  2706

  PDF: 1001
• 

  Short story of antirheumatic therapy.VIII. The immunodepressants

  G. Pasero, P. Marson

  44-54

  19-03-2012

  Published: 19 March 2012

  1384

  PDF: 1451
• 

  Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment

  G. Farronato, C. Bellintani, U. Garagiola, P. Cressoni, P. Sarzi Puttini, F. Atzeni, M. Cazzola

  254-257

  06-11-2014

  Published: 6 November 2014

  2270

  PDF: 1251
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  Published: 31 October 2013

  6690

  PDF: 2419
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  Published: 6 July 2018

  2358

  PDF: 1228
• 

  Possible relationship between certolizumab pegol and arrhythmias: report of two cases

  R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

  104-108

  09-09-2016

  Published: 9 September 2016

  1432

  PDF: 913
• 

  Work-related carpal tunnel syndrome treatment: a cross-sectional study among 106 patients

  M. Aouatef, B. Asma, H. Hajer, A. Charfeddine, B. Lamia, K. Taoufik

  59-64

  03-08-2017

  Published: 3 August 2017

  2474

  PDF: 1185
• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  Published: 27 March 2018

  5455

  PDF: 3248
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  Published:

  1451

  PDF: 883
• 

  Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

  A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

  350-359

  20-12-2012

  Published: 20 December 2012

  2813

  PDF: 2565
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  Published: 6 November 2014

  2484

  PDF: 1397
• 

  IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

  S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

  40-43

  19-03-2012

  Published: 19 March 2012

  819

  PDF: 1477
• 

  Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs

  E. Lubrano, R. Scarpa

  107-112

  05-06-2012

  Published: 5 June 2012

  1243

  PDF: 1180
• 

  Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients

  S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo

  326-334

  11-12-2012

  Published: 11 December 2012

  1547

  PDF: 767
• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  Published: 28 March 2013

  3390

  PDF: 1212
• 

  Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, M.S. Soleymani

  08-05-2023

  Published: 8 May 2023

  1216

  PDF: 530
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  Published: 27 March 2018

  1973

  PDF: 1520
• 

  Emerging therapies for osteoporosis

  G. Minisola, A. Iuliano, I. Prevete

  112-124

  28-07-2014

  Published: 28 July 2014

  1760

  PDF: 1343
• 

  Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

  F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

  97-102

  09-02-2016

  Published: 9 February 2016

  1932

  PDF: 1191
• 

  Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

  S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

  286-291

  17-03-2014

  Published: 17 March 2014

  2415

  PDF: 1135
• 

  Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

  C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

  109-111

  09-09-2016

  Published: 9 September 2016

  1628

  PDF: 1134
• 

  Bradykinin and its role in osteoarthritis

  L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti

  97-104

  23-07-2013

  Published: 23 July 2013

  3016

  PDF: 1794
• 

  The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis

  A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti

  65-71

  09-09-2016

  Published: 9 September 2016

  1701

  PDF: 1029
• 

  Comorbidity in polymyalgia rheumatica

  C. Chatzigeorgiou, S.L. Mackie

  35-43

  27-03-2018

  Published: 27 March 2018

  3227

  PDF: 1944
• 

  Pain in rheumatoid arthritis: a critical review

  P. Sarzi-Puttini, F. Salaffi, M. Di Franco, L. Bazzichi, G. Cassisi, R. Casale, M. Cazzola, S. Stisi, M. Battellino, F. Atzeni

  18-27

  06-06-2014

  Published: 6 June 2014

  5385

  PDF: 3333
• 

  Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review

  A. Minelli, A. Vaona

  151-157

  19-07-2012

  Published: 19 July 2012

  1596

  PDF: 1421
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  Published: 6 November 2014

  2123

  PDF: 1507
• 

  Intra-articular therapy with tumor necrosis factor-α antagonists: an update

  S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

  257-263

  14-03-2014

  Published: 14 March 2014

  2401

  PDF: 1175
• 

  Guidelines on prevention and treatment of vitamin D deficiency

  S. Adami, E. Romagnoli, V. Carnevale, A. Scillitani, A. Giusti, M. Rossini, D. Gatti, R. Nuti, S. Minisola

  129-147

  09-11-2011

  Published: 9 November 2011

  10244

  PDF: 32632
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  Published: 23 July 2020

  684

  PDF: 515
• 

  Successful treatment of refractory adult onset Still’s disease with rituximab

  N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

  159-162

  16-12-2016

  Published: 16 December 2016

  1982

  PDF: 1137
• 

  Acute colchicine overdose: report of three cases

  A. Aghabiklooei, N. Zamani, H. Hassanian-Moghaddam, S. Nasouhi, M. Mashayekhian

  307-311

  17-03-2014

  Published: 17 March 2014

  3683

  PDF: 1478
• 

  Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia

  K. Thieme, D.C. Turk

  275-285

  28-09-2012

  Published: 28 September 2012

  2917

  PDF: 2875
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  Published: 28 July 2014

  3417

  PDF: 2131
• 

  Sarcoidosis presenting as orbital pseudotumor

  S. Kobak, A. Topaloglu, G. Öncel, A. Karaarslan

  78-81

  16-09-2015

  Published: 16 September 2015

  1810

  PDF: 989

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  Published:

  1188

  PDF: 1007
• 

  Male osteoporosis

  A. Giusti, G. Bianchi

  136-143

  28-07-2014

  Published: 28 July 2014

  2446

  PDF: 1495
• 

  Management of cutaneous discomfort in patients with scleroderma: a clinical trial

  M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

  240-247

  18-12-2013

  Published: 18 December 2013

  3120

  PDF: 1009
• 

  Octogenarian with an untreated femoral neck fracture: upright position during the postoperative course after aortic valve replacement

  M. Polastri, L. Di Marco, S. Cantagalli, M. Di Eusanio

  26-28

  30-06-2015

  Published: 30 June 2015

  1208

  PDF: 691

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  Published:

  1648

  PDF: 1654
• 

  Effects of secukinumab on serum adipocytokines: preliminary data

  A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi

  105-110

  21-09-2017

  Published: 21 September 2017

  2565

  PDF: 1346